How to Buy Biotech Stocks This Summer

Now that the coronavirus vaccine race is over and the hype for vaccine stocks is fading, biotech investors will need to go back to basics if they want to pick the right stocks for the next few years. In short, that means looking at companies with promising therapies in development and understanding where their projects are in the pipeline. Squinting at a company's earnings reports is worth doing, but it won't always be enough of an edge to pad your portfolio.